Influence of organic solvents on nanoparticle formation and surfactants on release behaviour in-vitro using costunolide as model anticancer agent

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 4, 2014, Pages 638-645

  Vineeth, P ^a   Rao Vadaparthi, P R ^a   Kumar, K ^a   Babu, B DILEEP J ^a   Veerabhadra Rao, A ^b   Suresh Babu, K ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Costunolide; Modified O W single emulsion solvent evaporation; Nanoparticles; PLGA

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; COSTUNOLIDE; NANOPARTICLE; ORGANIC SOLVENT; POLYGLACTIN; SURFACTANT;

ARTICLE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EMULSION; ENTRAPMENT EFFICIENCY; GLOBULE SIZE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYSICAL PARAMETERS; PHYSICAL PHENOMENA; PROCESS OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84900385771     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Van Vlerken L. E, Amiji M.M. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv. 2006; 3: 205-16.
2. Ruenraroengsak P, Cook J. M, Florence A.T. Nanosystem drug targeting: facing up to complex realities. J. Control. Release. 2010; 141: 265-276.
3. Leroux J. C, Allemann E, Jaeghere F. D, Doelker E, Gurny R. Biodegradable nanoparticles from sustained release formulations to improved site specific drug delivery. J Control Release.1996; 39(2-3): 339-350.
4. Davis S. S, Illum L, Moghimi S.M. Microspheres for targeting drugs to specific body sites. J Control Release. 1993; 24(1-3): 157-163.
5. Kumari A, Yadav S. K, Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B Biointerfaces. 2010; 75: 1-18.
6. Cragg GM, Newman DJ. Plants as source of anticancer agents. J Ethnopharmacol. 2005; 100: 72-79.
7. Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J Clin Oncol.2009; 27: 2712-25.
8. Harvey AL. Natural products in drug discovery. Drug DiscovToday. 2008; 13: 894-901.
9. Paul A, Bawdekar A. S, Joshi R. S, Somashekara Rao K, Kelker G. R, Battacharya S. C. Perf. Ess. Oil. Rec. 1960; 15: 115.
10. Zhang S, Won Y. K, Ong C. N, Shen H.M. Anti-cancer potential of sesquiterpene lactones bioactivity and molecular mechanisms. Curr Med Chem Anticancer Agents. 2005; 5:239-49.
11. Budavari S, O'Neil MJ, Smith A, Heckelman PE. The Merck Index. An encyclopedia chemicals, drugs and biologicals.3rd edition. New Jersey: Merck and Co. pp. 2001;13-1082.
12. Mu L, Feng S.S. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol(R): PLGA nanoparticles containing vitamin E TPGS. J Control Release. 2003; 86:33-48.
13. Song K. C, Lee H. S, Choung I. Y, Cho K. I, Ahn Y, Choi E.J. The effect of type of organic phase solvents on the particle size of poly(D, Llactide-coglycolide) nanoparticles. Coll Surf A Physicochem Eng Aspects. 2006; 276: 162-167.
14. Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int. J. Pharm.1999; 187: 143-152.
15. Jeon H. J, Jeong Y. L, Jang M. K, Park Y. H, Nah J.W. Effect of solvent on the Preparation of surfactant-free poly(d, l-lactide-coglycolide) nanoparticles and norfloxacin release characteristics. Int. J. Pharm.2000; 207: 99-108.
16. Mu L, Feng S.S. Vitamin E TPGS used as emulsifier in the solvent evaporation technique for fabrication of polymeric nanospheres for controlled release of paclitaxel. J Con Rel. 2002; 80: 129-144.